Konstantinos Papadakis

About me

Licensed Medical Doctor, graduate of the Medical School of the National and Kapodistrian University of Athens, and currently PhD candidate at the Department of Oncology–Pathology, Karolinska Institutet.
My work focuses on translational and clinical research in malignant melanoma within the field of immuno-oncology. I study how the immune system responds in melanoma patients undergoing immunotherapy, with or without radiation therapy, with the ultimate goal of optimizing treatment strategies toward personalized care, reduced toxicity, and improved survival and quality of life.

ImmunOncology | Malignant Melanoma | Skin cancer | Skin Immunology | Dermatology & Venereology

Journal article: ACTA ONCOLOGICA. 2026;65:126-130
SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial
Helgadottir H; Carneiro A; Portelli F; Papadakis K; Björkström K; Yang M; Johansson I; Skogvall Svensson I; Jazrawi A; Hallgren A; Harbst K; Bark R; Egyhazi Brage S; Berglund A; Isaksson K; Wickström S; Nilsson J; Ny L; Jönsson G; Olofsson Bagge R
Article: ACTA ONCOLOGICA. 2025;64:1102-1108
POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers
Papadakis K; Portelli F; Schultz K; Sterky HO; Vassilaki I; Lapins J; Sargen MR; Obolenski S; Adams DJ; Yang M; Hoiom V; Helgadottir H
Article: EXPERIMENTAL CELL RESEARCH. 2024;437(2):114015
The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia
Enlund S; Sinha I; Neofytou C; Amor AR; Papadakis K; Nilsson A; Jiang Q; Hermanson O; Holm F

Phd Student, Department of Oncology-Pathology, Karolinska Institutet, 2025-2026
Research Assistant, Department of Oncology-Pathology, Karolinska Institutet, 2025-2025